These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24942408)

  • 1. A unique role for retrospective studies in clinical oncology.
    Markman M
    Oncology; 2014; 86(5-6):350. PubMed ID: 24942408
    [No Abstract]   [Full Text] [Related]  

  • 2. [Successful treatment of a patient with recurrent ovarian clear cell adenocarcinoma under combination chemotherapy of 5-FU (civ) and low-dose CDDP (i.v.)].
    Sakaihara M; Sakai K; Hara Y; Kataoka S; Tabata M; Hanatani K; Hareyama H
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):127-30. PubMed ID: 10660745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy for recurrent ovarian cancer].
    Nishimura H; Imamura K; Chang C
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1124-8. PubMed ID: 8751798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy for stage i ovarian clear cell carcinoma: is it necessary for stage IA?
    Mizuno M; Kajiyama H; Shibata K; Mizuno K; Yamamuro O; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
    Int J Gynecol Cancer; 2012 Sep; 22(7):1143-9. PubMed ID: 22801028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-platinum combination chemotherapy for advanced or recurrent ovarian clear cell adenocarcinoma: a multicenter trial.
    Utsunomiya H; Akahira J; Tanno S; Moriya T; Toyoshima M; Niikura H; Ito K; Morimura Y; Watanabe Y; Yaegashi N
    Int J Gynecol Cancer; 2006; 16(1):52-6. PubMed ID: 16445610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-line chemotherapy in recurrent clear cell ovarian cancer: results from the multicenter italian trials in ovarian cancer (MITO-9).
    Esposito F; Cecere SC; Magazzino F; Katsaros D; Ottaiano A; Gadducci A; Pisano C; Scalone S; Rabaiotti E; Salutari V; Cormio G; Canuto EM; Greggi S; Savarese A; Marinaccio M; Scollo P; Santeufemia DA; Sacco C; Facchini G; Pignata S
    Oncology; 2014; 86(5-6):351-8. PubMed ID: 24942520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian Cancer.
    Boisen MM; Lesnock JL; Richard SD; Beriwal S; Kelley JL; Zorn KK; Edwards RP
    Int J Gynecol Cancer; 2016 May; 26(4):626-31. PubMed ID: 27051048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: an analysis of fully staged patients.
    Takada T; Iwase H; Iitsuka C; Nomura H; Sakamoto K; Omatsu K; Takeshima N; Takizawa K
    Int J Gynecol Cancer; 2012 May; 22(4):573-8. PubMed ID: 22398705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clear clinical remission of a diffuse metastasized ovarian clear cell carcinoma with third line chemotherapy.
    Debois JM
    Acta Obstet Gynecol Scand; 1997 Aug; 76(7):709-12. PubMed ID: 9292651
    [No Abstract]   [Full Text] [Related]  

  • 10. [Colonic perforation in a patient treated with combination chemotherapy for recurrent ovarian clear cell adenocarcinoma].
    Shitara K; Munakata M; Ishiguro A; Kudo T; Okada R; Tomioka R; Mitobe S; Yokoyama S; Sakata Y
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1497-1500. PubMed ID: 17033246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response criteria can be misleading when drawing conclusion regarding neoadjuvant chemotherapy in advanced ovarian cancer.
    Bellati F; Gasparri ML; Caccetta J; Palaia I; Benedetti panici P
    J Surg Oncol; 2012 Sep; 106(4):529; author reply 527-8. PubMed ID: 22488017
    [No Abstract]   [Full Text] [Related]  

  • 12. Cisplatin, epirubicin, and ifosfamide versus cisplatin, epirubicin, and cyclophosphamide in clear cell carcinoma of the ovary.
    Nishida T; Sugiyama T; Yakushiji M
    Gynecol Oncol; 1997 Nov; 67(2):230. PubMed ID: 9367714
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of neo-JP therapy in the treatment of ovarian carcinoma].
    Matsunami K; Takagi H; Hasegawa Y
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):153-5. PubMed ID: 7826073
    [No Abstract]   [Full Text] [Related]  

  • 14. Second-look operation in clear cell carcinoma of the ovary.
    Nishida T; Sugiyama T
    Int J Gynaecol Obstet; 1997 Sep; 58(3):331-2. PubMed ID: 9286875
    [No Abstract]   [Full Text] [Related]  

  • 15. Paclitaxel and cisplatin combination chemotherapy in recurrent epithelial ovarian cancer.
    Goldberg JM; Piver MS; Hempling RE; Recio FO
    Gynecol Oncol; 1996 Dec; 63(3):312-7. PubMed ID: 8946864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic Debulking Surgery in the Management of Advanced Ovarian Cancer After Neoadjuvant Chemotherapy.
    Corrado G; Mancini E; Cutillo G; Baiocco E; Vici P; Sergi D; Patrizi L; Saltari M; Baffa A; Vizza E
    Int J Gynecol Cancer; 2015 Sep; 25(7):1253-7. PubMed ID: 26111273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
    Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary.
    Crotzer DR; Sun CC; Coleman RL; Wolf JK; Levenback CF; Gershenson DM
    Gynecol Oncol; 2007 May; 105(2):404-8. PubMed ID: 17292461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of adjuvant chemotherapy for stage I ovarian carcinoma with intraoperative tumor capsule rupture.
    Shimizu D; Sato N; Sato T; Makino K; Kito M; Shirasawa H; Kumagai J; Terada Y
    J Obstet Gynaecol Res; 2015 Mar; 41(3):432-9. PubMed ID: 25330897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete remission of recurrent ovarian clear cell carcinoma by chemotherapy with bevacizumab, trabectedin and oxaliplatin.
    Takano M; Ikeda Y; Kudoh K; Kita T; Sasaki N; Kikuchi Y
    J Obstet Gynaecol Res; 2013 Apr; 39(4):872-5. PubMed ID: 23167774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.